Company Filing History:
Years Active: 2013-2025
Title: Hyung Jun Ahn: Innovator in Cancer Treatment
Introduction
Hyung Jun Ahn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 4 patents, Ahn is recognized for his work in developing pharmaceutical compositions aimed at combating cancer.
Latest Patents
One of Ahn's latest patents is a pharmaceutical composition for preventing or treating cancer that comprises a kinesin spindle protein (KSP) inhibitor and a mitosis inhibitor. This invention relates to a method of treating cancer by administering a pharmaceutical composition to individuals suspected of having cancer, excluding humans, in a pharmaceutically effective amount. The composition includes an agent capable of inhibiting the expression of KSP along with a mitosis inhibitor.
Another notable patent is a viral complex that includes shRNA and an anti-EpCAM antibody. This invention involves a viral vector capable of delivering shRNA that suppresses the expression of the epidermal growth factor receptor (EGFR) to a cell. The complex is designed to treat cancer by administering the viral complex or the pharmaceutical composition to subjects with cancer that overexpresses EpCAM. The anti-EpCAM antibody-AAV2/shEGFR complex significantly reduces EGFR expression in tumor cells without inducing an immune response, thereby promoting tumor cell death.
Career Highlights
Hyung Jun Ahn is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
Ahn collaborates with notable colleagues, including Ick Chan Kwon and Kuiwon Choi, who contribute to his research efforts and innovations in the field of cancer treatment.
Conclusion
Hyung Jun Ahn's contributions to cancer treatment through his innovative patents highlight his role as a leading inventor in the medical field. His work continues to pave the way for more effective and safe cancer therapies.